Skip to main content
Premium Trial:

Request an Annual Quote

GE Healthcare to be GeneBio's Latin American Distributor

NEW YORK (GenomeWeb News) – GE Healthcare will distribute Geneva Bioinformatics’ protein identification and characterization software and other products in Latin American, GeneBio said today.
 
Under the agreement, the São Paulo, Brazil-based GE Healthcare Life Sciences Latin America will distribute the Phenyx MS identification platform, its Aldente product for positive matrix factorization analysis, and its Daemon and other mass spectrometry-related products throughout the region.
 
GeneBio’s Phenyx software, which was developed through a collaboration with the Swiss Institute of Bioinformatics, was “designed to meet the concurrent demands of high-throughput MS data analysis and dynamic results assessment,” the Geneva-based company said.
 
GE Healthcare has been distributing GeneBio’s Melanie imaging platform since 2004, the company said.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.